vs
AMREP CORP.（AXR）与NeuroPace Inc（NPCE）财务数据对比。点击上方公司名可切换其他公司
NeuroPace Inc的季度营收约是AMREP CORP.的1.8倍（$26.6M vs $14.6M），AMREP CORP.净利率更高（21.6% vs -10.3%，领先31.9%），AMREP CORP.同比增速更快（93.8% vs 23.9%），AMREP CORP.自由现金流更多（$5.4M vs $409.0K），过去两年NeuroPace Inc的营收复合增速更高（21.1% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
NeuroPace Inc是一家专注于神经调控技术的医疗科技企业，核心产品为可植入式响应神经刺激系统，主要用于治疗药物难治性癫痫，通过与医疗机构合作，为北美及部分全球市场的患者提供个性化治疗方案，降低癫痫发作频率。
AXR vs NPCE — 直观对比
营收规模更大
NPCE
是对方的1.8倍
$14.6M
营收增速更快
AXR
高出69.9%
23.9%
净利率更高
AXR
高出31.9%
-10.3%
自由现金流更多
AXR
多$5.0M
$409.0K
两年增速更快
NPCE
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $26.6M |
| 净利润 | $3.1M | $-2.7M |
| 毛利率 | — | 77.4% |
| 营业利润率 | 20.6% | -6.6% |
| 净利率 | 21.6% | -10.3% |
| 营收同比 | 93.8% | 23.9% |
| 净利润同比 | 338.9% | 48.0% |
| 每股收益（稀释后） | $0.58 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRNPCE
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $26.6M | ||
| Q3 25 | $17.9M | $27.4M | ||
| Q2 25 | $11.2M | $23.5M | ||
| Q1 25 | $7.5M | $22.5M | ||
| Q4 24 | $11.9M | $21.5M | ||
| Q3 24 | $19.1M | $21.1M | ||
| Q2 24 | $19.5M | $19.3M |
净利润AXRNPCE
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $-2.7M | ||
| Q3 25 | $4.7M | $-3.5M | ||
| Q2 25 | $3.9M | $-8.7M | ||
| Q1 25 | $717.0K | $-6.6M | ||
| Q4 24 | $4.0M | $-5.3M | ||
| Q3 24 | $4.1M | $-5.5M | ||
| Q2 24 | $4.1M | $-7.5M |
毛利率AXRNPCE
| Q1 26 | — | — | ||
| Q4 25 | — | 77.4% | ||
| Q3 25 | — | 77.4% | ||
| Q2 25 | — | 77.1% | ||
| Q1 25 | — | 77.0% | ||
| Q4 24 | — | 75.4% | ||
| Q3 24 | — | 73.2% | ||
| Q2 24 | — | 73.4% |
营业利润率AXRNPCE
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | -6.6% | ||
| Q3 25 | 34.4% | -9.5% | ||
| Q2 25 | 31.7% | -29.0% | ||
| Q1 25 | 5.7% | -22.9% | ||
| Q4 24 | 26.4% | -17.0% | ||
| Q3 24 | 26.1% | -20.1% | ||
| Q2 24 | 23.9% | -32.4% |
净利率AXRNPCE
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | -10.3% | ||
| Q3 25 | 26.3% | -12.8% | ||
| Q2 25 | 34.8% | -36.8% | ||
| Q1 25 | 9.5% | -29.3% | ||
| Q4 24 | 33.9% | -24.5% | ||
| Q3 24 | 21.3% | -25.9% | ||
| Q2 24 | 21.2% | -39.0% |
每股收益（稀释后）AXRNPCE
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $-0.08 | ||
| Q3 25 | $0.87 | $-0.11 | ||
| Q2 25 | $0.73 | $-0.26 | ||
| Q1 25 | $0.13 | $-0.21 | ||
| Q4 24 | $0.75 | $-0.16 | ||
| Q3 24 | $0.76 | $-0.19 | ||
| Q2 24 | $0.77 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $61.1M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | $19.0M |
| 总资产 | $143.9M | $105.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRNPCE
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $61.1M | ||
| Q3 25 | $48.9M | $60.0M | ||
| Q2 25 | $39.5M | $62.1M | ||
| Q1 25 | $36.9M | $66.3M | ||
| Q4 24 | $40.1M | $52.8M | ||
| Q3 24 | $40.4M | $56.8M | ||
| Q2 24 | $29.7M | $55.5M |
总债务AXRNPCE
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
股东权益AXRNPCE
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $19.0M | ||
| Q3 25 | $134.7M | $18.5M | ||
| Q2 25 | $130.0M | $19.4M | ||
| Q1 25 | $126.0M | $24.3M | ||
| Q4 24 | $125.1M | $8.0M | ||
| Q3 24 | $122.2M | $9.8M | ||
| Q2 24 | $118.0M | $9.9M |
总资产AXRNPCE
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $105.6M | ||
| Q3 25 | $140.7M | $107.3M | ||
| Q2 25 | $133.8M | $106.1M | ||
| Q1 25 | $128.9M | $110.2M | ||
| Q4 24 | $129.1M | $94.6M | ||
| Q3 24 | $127.0M | $96.3M | ||
| Q2 24 | $122.8M | $94.4M |
负债/权益比AXRNPCE
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $506.0K |
| 自由现金流经营现金流 - 资本支出 | $5.4M | $409.0K |
| 自由现金流率自由现金流/营收 | 37.0% | 1.5% |
| 资本支出强度资本支出/营收 | 0.1% | 0.4% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | $-11.3M |
8季度趋势，按日历期对齐
经营现金流AXRNPCE
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $506.0K | ||
| Q3 25 | $9.5M | $-1.9M | ||
| Q2 25 | $10.2M | $-2.1M | ||
| Q1 25 | $-3.2M | $-7.5M | ||
| Q4 24 | $-182.0K | $-4.8M | ||
| Q3 24 | $10.7M | $-1.7M | ||
| Q2 24 | $10.7M | $-3.9M |
自由现金流AXRNPCE
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $409.0K | ||
| Q3 25 | $9.5M | $-2.0M | ||
| Q2 25 | $9.7M | $-2.3M | ||
| Q1 25 | $-3.3M | $-7.5M | ||
| Q4 24 | $-268.0K | $-4.8M | ||
| Q3 24 | $10.7M | $-1.8M | ||
| Q2 24 | $10.3M | $-4.0M |
自由现金流率AXRNPCE
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | 1.5% | ||
| Q3 25 | 53.2% | -7.2% | ||
| Q2 25 | 86.4% | -9.6% | ||
| Q1 25 | -43.4% | -33.4% | ||
| Q4 24 | -2.3% | -22.5% | ||
| Q3 24 | 55.8% | -8.7% | ||
| Q2 24 | 52.5% | -20.6% |
资本支出强度AXRNPCE
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 0.4% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 5.2% | 0.7% | ||
| Q1 25 | 0.3% | 0.2% | ||
| Q4 24 | 0.7% | 0.2% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 2.3% | 0.3% |
现金转化率AXRNPCE
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
